The strong induction of IFITM1 may occur in a small portion of tumor cells in the primary tumor tissues because we detected relatively weak IFITM1 expression in the orthotopic tumors in our model and the primary tumors of patients with SCLC (Figure 2 and Figure 3). Here, IFITM1 is linked to small cell lung carcinoma.